Our results supported the role of KIT mutations as an aggressiveness marker for melanoma patients and suggested that the development of the pathogenesis of KIT-mutated melanomas is independent of the common etiopathogenic pathways (nevus-proneness and chronic sun damage). The gene discussed is KIT; the disease is melanoma.